Corynebacterium parakroppenstedtii secretes a novel glycolipid to promote the development of granulomatous lobular mastitis.
Journal
Signal transduction and targeted therapy
ISSN: 2059-3635
Titre abrégé: Signal Transduct Target Ther
Pays: England
ID NLM: 101676423
Informations de publication
Date de publication:
21 Oct 2024
21 Oct 2024
Historique:
received:
27
04
2024
accepted:
18
09
2024
revised:
05
09
2024
medline:
21
10
2024
pubmed:
21
10
2024
entrez:
20
10
2024
Statut:
epublish
Résumé
Granulomatous lobular mastitis (GLM) is a chronic idiopathic granulomatous mastitis of the mammary gland characterized by significant pain and a high propensity for recurrence, the incidence rate has gradually increased, and has become a serious breast disease that should not be ignored. GLM is highly suspected relative to microbial infections, especially those of Corynebacterium species; however, the mechanisms involved are unclear, and prevention and treatment are difficult. In this study, we demonstrated the pathogenicity of Corynebacterium parakroppenstedtii in GLM using Koch's postulates. Based on the drug sensitization results of C. parakroppenstedtii, and utilizing a retrospective study in conjunction with a comprehensive literature review, we suggested an efficacious, targeted antibiotic treatment strategy for GLM. Subsequently, we identified the pathogenic factor as a new type of glycolipid (named corynekropbactins) secreted by C. parakroppenstedtii. Corynekropbactins may chelate iron, cause the death of mammary cells and other mammary -gland-colonizing bacteria, and increase the levels of inflammatory cytokines. We further analyzed the prevalence of C. parakroppenstedtii infection in patients with GLM. Finally, we suggested that the lipophilicity of C. parakroppenstedtii may be associated with its infection route and proposed a possible model for the development of GLM. This research holds significant implications for the clinical diagnosis and therapeutic management of GLM, offering new insights into targeted treatment approaches.
Identifiants
pubmed: 39428541
doi: 10.1038/s41392-024-01984-0
pii: 10.1038/s41392-024-01984-0
doi:
Substances chimiques
Glycolipids
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
292Informations de copyright
© 2024. The Author(s).
Références
Kessler, E. & Wolloch, Y.Granulomatous mastitis: a lesion clinically simulating carcinoma. Am. J. Clin. Pathol. 58, 642–646 (1972).
pubmed: 4674439
doi: 10.1093/ajcp/58.6.642
Altintoprak, F., Kivilcim, T. & Ozkan, O. V. Aetiology of idiopathic granulomatous mastitis. World J. Clin. Cases 2, 852–858 (2014).
pubmed: 25516860
pmcid: 4266833
doi: 10.12998/wjcc.v2.i12.852
Martinez-Ramos, D. et al. Idiopathic granulomatous mastitis: A systematic review of 3060 patients. Breast J. 25, 1245–1250 (2019).
pubmed: 31273861
doi: 10.1111/tbj.13446
Pala, E. E. et al. Granulomatous mastitis: A clinical and diagnostic dilemma. Turk. Patoloji. Derg. 38, 40–45 (2021).
Azizi, A. et al. Idiopathic granulomatous mastitis: Management and predictors of recurrence in 474 patients. Breast J. 26, 1358–1362 (2020).
pubmed: 32249491
doi: 10.1111/tbj.13822
Chang, C. M., Lin, M. C. & Yin, W. Y. Risk of breast cancer in women with non-lactational mastitis. Sci. Rep. 9, 15587 (2019).
pubmed: 31666573
pmcid: 6821708
doi: 10.1038/s41598-019-52046-3
Yuan, Q. Q. et al. Management of granulomatous lobular mastitis: an international multidisciplinary consensus (2021 edition). Mil. Med. Res. 9, 20 (2022).
pubmed: 35473758
pmcid: 9040252
Sener Bahce, Z. & Aktas, H. Patients with idiopathic granulomatous mastitis accompanied by erythema nodosum. Int. J. Clin. Pract. 75, e13928 (2021).
pubmed: 33305438
doi: 10.1111/ijcp.13928
Emsen, A., Koksal, H., Ucaryilmaz, H., Kadoglou, N. & Artac, H. The alteration of lymphocyte subsets in idiopathic granulomatous mastitis. Turk. J. Med. Sci. 51, 1905–1911 (2021).
pubmed: 33862673
pmcid: 8569769
doi: 10.3906/sag-2012-192
Wong, S. C. Y. et al. Corynebacterium kroppenstedtii is an emerging cause of mastitis especially in patients with psychiatric illness on antipsychotic medication. Open Forum Infect. Di 4, ofx096 (2017).
doi: 10.1093/ofid/ofx096
Li, J. & McGregor, H. P. Idiopathic granulomatous mastitis associated with hyperprolactinemia: a nonoperative approach. Breast J. 23, 742–744 (2017).
pubmed: 28845595
doi: 10.1111/tbj.12914
Nikolaev, A., Blake, C. N. & Carlson, D. L. Association between hyperprolactinemia and granulomatous mastitis. Breast J. 22, 224–231 (2016).
pubmed: 26705962
doi: 10.1111/tbj.12552
Akahane, K. et al. Therapeutic strategy for granulomatous lobular mastitis: a clinicopathological study of 12 patients. Nagoya J. Med. Sci. 75, 193–200 (2013).
pubmed: 24640175
pmcid: 4345679
Akbulut, S., Yilmaz, D. & Bakir, S. Methotrexate in the management of idiopathic granulomatous mastitis: review of 108 published cases and report of four cases. Breast J. 17, 661–668 (2011).
pubmed: 21951547
doi: 10.1111/j.1524-4741.2011.01162.x
Kok, K. Y. & Telisinghe, P. U. Granulomatous mastitis: presentation, treatment and outcome in 43 patients. Surgeon 8, 197–201 (2010).
pubmed: 20569938
doi: 10.1016/j.surge.2010.02.002
Korkut, E., Akcay, M. N., Karadeniz, E., Subasi, I. D. & Gursan, N. Granulomatous Mastitis: A Ten-Year Experience at a University Hospital. Eurasia. J. Med. 47, 165–173 (2015).
doi: 10.5152/eurasianjmed.2015.118
Bhattarai, P. et al. Idiopathic granulomatous mastitis: experience at a New York hospital. Ann. R. Coll. Surg. Engl. 104, 543–547 (2021).
pubmed: 34812662
doi: 10.1308/rcsann.2021.0239
Williams, M. S., McClintock, A. H., Bourassa, L. & Laya, M. B. Treatment of granulomatous mastitis: is there a role for antibiotics? Eur. J. Breast Health 17, 239–246 (2021).
pubmed: 34263151
pmcid: 8246047
doi: 10.4274/ejbh.galenos.2021.2021-3-1
Farouk, O. et al. Rifampicin for idiopathic granulomatous lobular mastitis: A promising alternative for treatment. World J. Surg. 41, 1313–1321 (2017).
pubmed: 28050664
doi: 10.1007/s00268-016-3857-7
Dobinson, H. C. et al. Antimicrobial treatment options for granulomatous mastitis caused by Corynebacterium species. J. Clin. Microbiol. 53, 2895–2899 (2015).
pubmed: 26135858
pmcid: 4540898
doi: 10.1128/JCM.00760-15
Wang, Y. S. et al. Granulomatous lobular mastitis associated with Mycobacterium abscessus in south China: A case report and review of the literature. Case Rep. Infect. Dis. 2017, 7052908 (2017).
pubmed: 28286681
pmcid: 5329686
Wang, Y., LeGolvan, M., Chapin, K. & Mainiero, M. Cystic neutrophilic granulomatous mastitis with Corynebacterium and Staphylococcus mimicking breast carcinoma. Clin. Case Rep. 6, 2208–2210 (2018).
pubmed: 30455922
pmcid: 6230645
doi: 10.1002/ccr3.1801
Nath, S. R., Mathew, A. P., Mohan, A. & Anila, K. R. Rhodococcus equi granulomatous mastitis in an immunocompetent patient. J. Med. Microbiol. 62, 1253–1255 (2013).
pubmed: 23699061
doi: 10.1099/jmm.0.054346-0
Zardawi, I. M., Jones, F., Clark, D. A. & Holland, J. Gordonia terrae-induced suppurative granulomatous mastitis following nipple piercing. Pathology 36, 275–278 (2004).
pubmed: 15203738
doi: 10.1080/00313020410001692639
Li, X. Q. et al. New insights of Corynebacterium kroppenstedtii in granulomatous lobular mastitis based on nanopore sequencing. J. Invest. Surg. 35, 639–646 (2022).
pubmed: 34036894
doi: 10.1080/08941939.2021.1921082
Tariq, H. et al. Detection of Corynebacterium kroppenstedtii in granulomatous lobular mastitis using real-time polymerase chain reaction and sanger sequencing on formalin-fixed, paraffin-embedded tissues. Arch. Pathol. Lab. Med. 146, 749–754 (2022).
pubmed: 34506619
doi: 10.5858/arpa.2021-0061-OA
Johnstone, K. J. et al. Cystic neutrophilic granulomatous mastitis associated with Corynebacterium including Corynebacterium kroppenstedtii. Pathology 49, 405–412 (2017).
pubmed: 28442140
doi: 10.1016/j.pathol.2017.01.006
Bi, J. et al. Etiology of granulomatous lobular mastitis based on metagenomic next-generation sequencing. Int. J. Infect. Dis. 113, 243–250 (2021).
pubmed: 34673215
doi: 10.1016/j.ijid.2021.10.019
Naik, M. A., Korlimarla, A., Shetty, S. T., Fernandes, A. M. & Pai, S. A. Cystic neutrophilic granulomatous mastitis: A clinicopathological study with 16s rRNA sequencing for the detection of Corynebacteria in formalin-fixed paraffin-embedded tissue. Int. J. Surg. Pathol. 28, 371–381 (2020).
pubmed: 31870201
doi: 10.1177/1066896919896021
Luo, Q. et al. Classification of 27 Corynebacterium kroppenstedtii-like isolates associated with mastitis in China and descriptions of C. parakroppenstedtii sp. nov. and C. pseudokroppenstedtii sp. nov. Microbiol. Spectr. 10, e0137221 (2022).
pubmed: 35289670
doi: 10.1128/spectrum.01372-21
Saar, M. et al. Unveiling the etiology of peritonsillar abscess using next generation sequencing. Ann. Clin. Microb. Anti. 22, 98 (2023).
doi: 10.1186/s12941-023-00649-0
Wang, Q. Q. et al. The clinical value of metagenomic next-generation sequencing in the microbiological diagnosis of skin and soft tissue infections. Int. J. Infect. Dis. 100, 414–420 (2020).
pubmed: 32898669
doi: 10.1016/j.ijid.2020.09.007
Li, S. B. et al. Clinical characteristics and therapeutic strategy of granulomatous mastitis accompanied by a retrospective cohort study. Bmc Women’s Health 23, 388 (2023).
pubmed: 37491234
pmcid: 10369769
doi: 10.1186/s12905-023-02509-7
Chen, W. et al. Clinical characteristics and microbiota analysis of 44 patients with granulomatous mastitis. Front Microbiol 14, 1175206 (2023).
pubmed: 37138612
pmcid: 10150378
doi: 10.3389/fmicb.2023.1175206
Tauch, A., Fernandez-Natal, I. & Soriano, F. A microbiological and clinical review on Corynebacterium kroppenstedtii. Int. J. Infect. Dis. 48, 33–39 (2016).
pubmed: 27155209
doi: 10.1016/j.ijid.2016.04.023
Huang, Y. M. et al. Serum C-reactive protein and interleukin-6 levels as biomarkers for disease severity and clinical outcomes in patients with idiopathic granulomatous mastitis. J. Clin. Med. 10, 2077 (2021).
pubmed: 34066203
pmcid: 8150275
doi: 10.3390/jcm10102077
Zhou, F. et al. Efficacy and safety of rifampicin-based triple therapy for non-puerperal mastitis: A single-arm, open-label, prospective clinical trial. Int. J. Infect. Dis. 140, 25–30 (2024).
pubmed: 38142735
doi: 10.1016/j.ijid.2023.12.008
Khasheii, B., Mahmoodi, P. & Mohammadzadeh, A. Siderophores: Importance in bacterial pathogenesis and applications in medicine and industry. Microbiol. Res. 250, 126790 (2021).
pubmed: 34098495
doi: 10.1016/j.micres.2021.126790
Schwyn, B. & Neilands, J. B. Universal chemical assay for the detection and determination of siderophores. Anal. Biochem. 160, 47–56 (1987).
pubmed: 2952030
doi: 10.1016/0003-2697(87)90612-9
Ryll, R., Kumazawa, Y. & Yano, I. Immunological properties of trehalose dimycolate (cord factor) and other mycolic acid-containing glycolipids–a review. Microbiol Immunol. 45, 801–811 (2001).
pubmed: 11838897
doi: 10.1111/j.1348-0421.2001.tb01319.x
Klatt, S. et al. Identification of novel lipid modifications and intermembrane dynamics in Corynebacterium glutamicum using high-resolution mass spectrometry. J. Lipid Res. 59, 1190–1204 (2018).
pubmed: 29724782
pmcid: 6027913
doi: 10.1194/jlr.M082784
Kramer, J., Ozkaya O & Kummerli, R. Bacterial siderophores in community and host interactions. Nat. Rev. Microbiol 18, 152–163 (2020).
pubmed: 31748738
doi: 10.1038/s41579-019-0284-4
Bardsdale, W. L. & Pappenheimer Jr., A. M. Phage-host relationships in nontoxigenic and toxigenic diphtheria bacilli. J. Bacteriol. 67, 220–232 (1954).
pubmed: 13129217
doi: 10.1128/jb.67.2.220-232.1954
Raj, D. S. Role of interleukin-6 in the anemia of chronic disease. Semin. Arthritis Rheum. 38, 382–388 (2009).
pubmed: 18336871
doi: 10.1016/j.semarthrit.2008.01.006
Vlachodimitropoulou, E. et al. Eltrombopag: a powerful chelator of cellular or extracellular iron(III) alone or combined with a second chelator. Blood 130, 1923–1933 (2017).
pubmed: 28864815
doi: 10.1182/blood-2016-10-740241
Louden, B. C., Haarmann, D. & Lynne, A. M. Use of blue agar cas assay for siderophore detection. J. Microbiol. Biol. Educ. 12, 51–53 (2011).
pubmed: 23653742
pmcid: 3577196
doi: 10.1128/jmbe.v12i1.249
Arora, N. K. & Verma, M. Modified microplate method for rapid and efficient estimation of siderophore produced by bacteria. 3 Biotech 7, 381 (2017).
pubmed: 29109926
pmcid: 5658296
doi: 10.1007/s13205-017-1008-y
Liu, R. et al. A cell-free platform based on nisin biosynthesis for discovering novel lanthipeptides and guiding their overproduction in vivo. Adv. Sci. (Weinh.) 7, 2001616 (2020).
pubmed: 32995136
Asgin, N. & Otlu, B. Antimicrobial resistance and molecular epidemiology of Corynebacterium striatum isolated in a tertiary hospital in Turkey. Pathogens 9, 136 (2020).
pubmed: 32093060
pmcid: 7168331
doi: 10.3390/pathogens9020136
Chaumeil, P. A., Mussig, A. J., Hugenholtz, P. & Parks, D. H. GTDB-Tk: a toolkit to classify genomes with the Genome Taxonomy Database. Bioinformatics 36, 1925–1927 (2019).
pubmed: 31730192
pmcid: 7703759
doi: 10.1093/bioinformatics/btz848
Minh, B. Q. et al. IQ-TREE 2: New models and efficient methods for phylogenetic inference in the genomic era. Mol. Biol. Evol. 37, 1530–1534 (2020).
pubmed: 32011700
pmcid: 7182206
doi: 10.1093/molbev/msaa015
Kalyaanamoorthy, S., Minh, B. Q., Wong, T. K. F., von Haeseler, A. & Jermiin, L. S. ModelFinder: fast model selection for accurate phylogenetic estimates. Nat. Methods 14, 587–589 (2017).
pubmed: 28481363
pmcid: 5453245
doi: 10.1038/nmeth.4285
Letunic, I. & Bork, P. Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation. Nucleic Acids Res 49, W293–W296 (2021).
pubmed: 33885785
pmcid: 8265157
doi: 10.1093/nar/gkab301